{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:47:09Z","timestamp":1780361229365,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00259-017-3766-5","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T21:45:46Z","timestamp":1498686346000},"page":"2025-2033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The role of F-18 FDG PET\/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Ismaheel O.","family":"Lawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozipho E.","family":"Nyakale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lerwine M.","family":"Harry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe R.","family":"Modiselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred O.","family":"Ankrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse P.","family":"Msomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neo P.","family":"Mokgoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebatso G.","family":"Boshomane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe Van","family":"de Wiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-0625","authenticated-orcid":false,"given":"Mike M.","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"issue":"11","key":"3766_CR1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1023\/A:1008390028330","volume":"10","author":"M Spina","year":"1999","unstructured":"Spina M, Vaccher E, Carbone A, Tirelli U. Neoplastic complications of HIV infection. Ann Oncol. 1999;10(11):1271\u201386.","journal-title":"Ann Oncol"},{"issue":"1","key":"3766_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/COH.0000000000000327","volume":"12","author":"MS Shiels","year":"2017","unstructured":"Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS. 2017;12(1):6\u201311.","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"3766_CR3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3923\/ijcr.2016.92.100","volume":"12","author":"AM Mayor","year":"2016","unstructured":"Mayor AM, Santiago-Rodriguez EJ, Rios-Olivares E, Tortolero-Luna G, Hunter-Mellado RF. Malignancies trends in a Hispanic cohort of HIV persons in Puerto Rico before and after cART. Int J Cancer Res. 2016;12(2):92\u2013100.","journal-title":"Int J Cancer Res"},{"issue":"9581","key":"3766_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59\u201367.","journal-title":"Lancet"},{"issue":"3","key":"3766_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdv606","volume":"27","author":"JP Spano","year":"2016","unstructured":"Spano JP, Poizot-Martin I, Costagliola D, Bou\u00e9 F, Rosmorduc O, Lavol\u00e9 A, et al. Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH working group. Ann Oncol. 2016;27(3):397\u2013401.","journal-title":"Ann Oncol"},{"key":"3766_CR6","unstructured":"Statistics South Africa Mid-year population estimates, 2016; Available from: http:\/\/www.statsa.gov.za\/publications\/P0302\/P03022012.pdf . Accessed on 15 April 2017."},{"key":"3766_CR7","unstructured":"UNAIDS. AIDS by the number, 2016; Available from: http:\/\/www.unaids.orgs\/countries\/southafrica.pdf . Accessed on 15 April 2017."},{"key":"3766_CR8","doi-asserted-by":"publisher","first-page":"434375","DOI":"10.1155\/2011\/434375","volume":"2011","author":"RE Barth","year":"2011","unstructured":"Barth RE, Tempelman HA, Moraba R, Hoepelman AI. Long-term outcome of an HIV-treatment Programme in rural Africa: viral suppression despite early mortality. AIDS Res Treat. 2011;2011:434375. doi: 10.1155\/2011\/434375 .","journal-title":"AIDS Res Treat"},{"issue":"6","key":"3766_CR9","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/INF.0000000000001117","volume":"35","author":"J Bohlius","year":"2016","unstructured":"Bohlius J, Maxwell N, Spoerri A, Wainwright R, Sawry S, Poole J, et al. Incidence of AIDS-defining and other cancers in HIV-positive children in South Africa: record linkage study. Paediatr Infect Dis J. 2016;35(6):e164\u201370.","journal-title":"Paediatr Infect Dis J"},{"issue":"2","key":"3766_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transci.2011.01.014","volume":"44","author":"JM Warwick","year":"2011","unstructured":"Warwick JM, Sathekge MM. PET\/CT scanning with a high HIV\/AIDS prevalence. Transfus Apher Sci. 2011;44(2):167\u201372.","journal-title":"Transfus Apher Sci"},{"issue":"27","key":"3766_CR11","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and Responsw assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059\u201367.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3766_CR12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","volume":"20","author":"JYY Ngeow","year":"2009","unstructured":"Ngeow JYY, Quek RHH, Ng DCE, Hee SW, Tao M, Lim LC, et al. High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma. Ann Oncol. 2009;20(9):1543\u20137.","journal-title":"Ann Oncol"},{"issue":"2","key":"3766_CR13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00259-012-2280-z","volume":"40","author":"C Wiele Van de","year":"2013","unstructured":"Van de Wiele C, Kruse V, Smeets P, Sathekge M, Maes A, et al. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging. 2013;40(2):290\u2013301.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"3766_CR14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2016.10.029","volume":"97","author":"SA Milgrom","year":"2017","unstructured":"Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, et al. Chemotherapy response assessment by FDG-PET-CT in early-stage classical Hodgkin lymphoma: moving beyond the five-point Deauville score. Int J Radiat Oncol Biol Phys. 2017;97(2):333\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3766_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2967\/jnumed.116.176511","volume":"58","author":"S Bakhshi","year":"2017","unstructured":"Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, et al. Posttreatment PET\/CT rather than interim PET\/CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma: a prospective study comparing PET\/CT with conventional imaging. J Nucl Med. 2017;58(4):577\u201383.","journal-title":"J Nucl Med"},{"issue":"3","key":"3766_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cncr.29066","volume":"121","author":"JJ Castillo","year":"2015","unstructured":"Castillo JJ, Bower M, Br\u00fchlmann J, Novak U, Furrer H, Tanaka PY, et al. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Cancer. 2015;121(3):423\u201331.","journal-title":"Cancer"},{"issue":"33","key":"3766_CR17","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2012.41.8137","volume":"30","author":"M Hentrich","year":"2012","unstructured":"Hentrich M, Berger M, Wyen C, Siehl J, Rockstroh JK, M\u00fcller M, et al. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study. J Clin Oncol. 2012;30(33):4117\u201323.","journal-title":"J Clin Oncol"},{"key":"3766_CR18","doi-asserted-by":"publisher","unstructured":"Sorigu\u00e9 M, Garcia O, Tapia G, Baptista MJ, Moreno M, Mate JL, et al. HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine. AIDS. 2017; doi: 10.1097\/QAD.0000000000001487 .","DOI":"10.1097\/QAD.0000000000001487"},{"issue":"2","key":"3766_CR19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3766_CR20","doi-asserted-by":"publisher","unstructured":"Lawal I, Lengana T, Ololade K, Boshomane T, Reyneke F, Modiselle M, et al. 18F-FDG PET\/CT in the detection of asymptomatic malignant melanoma recurrence. Nuklearmedizin. 2017; doi: 10.3413\/Nukmed-0864-16-11 .","DOI":"10.3413\/Nukmed-0864-16-11"},{"issue":"8","key":"3766_CR21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma. 2009;50(8):1257\u201360.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3766_CR22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/QAI.0b013e31815e722b","volume":"47","author":"J Barenguer","year":"2008","unstructured":"Barenguer J, Miralles P, Ribera JM, Rubio R, Valencia E, Mahillo B, et al. Charcateristic and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47(2):422\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3766_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3324\/haematol.10479","volume":"92","author":"B Xicoy","year":"2007","unstructured":"Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, et al. Results of treatment with doxorubicin, Bleomycin, vinblastine and Dacarbazine in advanced stage, human immunodeficiency virus-related Hodgkin\u2019s lymphoma. Heamatologica. 2007;92(2):191\u20138.","journal-title":"Heamatologica"},{"issue":"1","key":"3766_CR24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bmb\/ldw035","volume":"120","author":"I Lawal","year":"2016","unstructured":"Lawal I, Sathekge M. F-18 FDG PET\/CT in cardiac and vascular inflammation and infection. Br Med Bull. 2016;120(1):55\u201374.","journal-title":"Br Med Bull"},{"issue":"4","key":"3766_CR25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00259-014-2701-2","volume":"41","author":"M Sathekge","year":"2014","unstructured":"Sathekge M. Differentiation of HIV-associated lymphoma from HIV-reactive adenopathy using quantitative FDG-PET and symmetry. Eur J Nucl Med Mol Imaging. 2014;41(4):593\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"3766_CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00259-013-2671-9","volume":"41","author":"JC Mhlanga","year":"2014","unstructured":"Mhlanga JC, Durand D, Tsai HL, Durand CM, Leal JP, Wang H, et al. Differentiation of HIV-associated lymphoma from HIV-associated reactive lymphadenopathy using quantitative PET and symmetry. Eur J Nucl Med Mol Imaging. 2014;41(4):596\u2013604.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"3766_CR27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.semnuclmed.2013.04.008","volume":"43","author":"M Sathekge","year":"2013","unstructured":"Sathekge M, Maes A, Van de Wiele C. FDG-PET in HIV infection and tuberculosis. Semin Nucl Med. 2013;43(5):349\u201366.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"3766_CR28","first-page":"5","volume":"4","author":"BD Cheson","year":"2015","unstructured":"Cheson BD. Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol. 2015;4(1):5.","journal-title":"Chin Clin Oncol"},{"issue":"33","key":"3766_CR29","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","volume":"30","author":"S Montoto","year":"2012","unstructured":"Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma using doxorubicin, Bloemycin, Vinblastin, and Dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30(33):4111\u20136.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3766_CR30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/cid\/civ627","volume":"61","author":"C Besson","year":"2015","unstructured":"Besson C, Lancar R, Prevot S, Brice P, Meyohas MC, Marchou B, et al. High risk features contrast with Favourable outcomes in HIV-associated Hodgkin lymphoma in the modern cART era, ANRS CO16 LYMPHOVIR cohort. Clin Infect Dis. 2015;61(9):1469\u201375.","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3766-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:45:54Z","timestamp":1659152754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3766-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}